1. Home
  2. ONTO vs NBY Comparison

ONTO vs NBY Comparison

Compare ONTO & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Onto Innovation Inc.

ONTO

Onto Innovation Inc.

HOLD

Current Price

$161.23

Market Cap

6.6B

Sector

Industrials

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

SELL

Current Price

$4.41

Market Cap

398.2M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
ONTO
NBY
Founded
1940
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
398.2M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
ONTO
NBY
Price
$161.23
$4.41
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$155.00
N/A
AVG Volume (30 Days)
799.0K
2.3M
Earning Date
02-05-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.55
0.47
Revenue
$1,002,336,000.00
$10,302,000.00
Revenue This Year
$3.72
$23.91
Revenue Next Year
$17.29
$32.05
P/E Ratio
$44.85
$210.99
Revenue Growth
6.38
390.34
52 Week Low
$85.88
$0.46
52 Week High
$228.42
$6.47

Technical Indicators

Market Signals
Indicator
ONTO
NBY
Relative Strength Index (RSI) 60.89 68.95
Support Level $146.79 $2.92
Resistance Level $162.80 $6.47
Average True Range (ATR) 6.27 0.85
MACD -0.50 0.31
Stochastic Oscillator 56.87 62.27

Price Performance

Historical Comparison
ONTO
NBY

About ONTO Onto Innovation Inc.

Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: